Talk:MindMed

The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.

JSFarman2 (talk · contribs) has been paid by MindMed on their behalf. Disclosed on user page User:JSFarman2

Articles for creation

	This article was reviewed by member(s) of WikiProject Articles for creation. The project works to allow users to contribute quality articles and media files to the encyclopedia and track their progress as they are developed. To participate, please visit the project page for more information.Articles for creationWikipedia:WikiProject Articles for creationTemplate:WikiProject Articles for creationAfC articles
	This article was accepted from this draft on 8 July 2021 by reviewer Nightenbelle (talk · contribs).

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine: Toxicology / Psychiatry Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by the Toxicology task force (assessed as Low-importance).
	Psychiatry portal This article is supported by the Psychiatry task force (assessed as Low-importance).

LSD neutralizer[edit]

Article says: "The development of a novel compound designed to shorten the duration or stop an LSD experience that would allow LSD to be more widely used in a therapeutic environment, was subsequently announced."

Link to announcement

The 'novel compund' is Ketanserin which is not novel. Should we include this in the article? 2A02:3030:403:5585:1DB8:CBCD:B142:EACB (talk) 15:23, 24 September 2021 (UTC)[reply]